000 01520 a2200385 4500
005 20250517194718.0
264 0 _c20190619
008 201906s 0 0 eng d
022 _a2163-8306
024 7 _a10.1002/psp4.12272
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMessinis, Dimitris E
245 0 0 _aTranslational systems pharmacology-based predictive assessment of drug-induced cardiomyopathy.
_h[electronic resource]
260 _bCPT: pharmacometrics & systems pharmacology
_c03 2018
300 _a166-174 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aCardiomyopathies
_xchemically induced
650 0 4 _aCardiotoxicity
650 0 4 _aComputational Biology
650 0 4 _aDoxorubicin
_xadverse effects
650 0 4 _aGene Regulatory Networks
_xdrug effects
650 0 4 _aHumans
650 0 4 _aModels, Biological
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aRegression Analysis
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTranslational Research, Biomedical
700 1 _aMelas, Ioannis N
700 1 _aHur, Junguk
700 1 _aVarshney, Navya
700 1 _aAlexopoulos, Leonidas G
700 1 _aBai, Jane P F
773 0 _tCPT: pharmacometrics & systems pharmacology
_gvol. 7
_gno. 3
_gp. 166-174
856 4 0 _uhttps://doi.org/10.1002/psp4.12272
_zAvailable from publisher's website
999 _c27987235
_d27987235